These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 15855163)
1. Cyclooxygenase-2-derived prostaglandin E2 promotes human cholangiocarcinoma cell growth and invasion through EP1 receptor-mediated activation of the epidermal growth factor receptor and Akt. Han C; Wu T J Biol Chem; 2005 Jun; 280(25):24053-63. PubMed ID: 15855163 [TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells. Han C; Michalopoulos GK; Wu T J Cell Physiol; 2006 Apr; 207(1):261-70. PubMed ID: 16331686 [TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor. Buchanan FG; Wang D; Bargiacchi F; DuBois RN J Biol Chem; 2003 Sep; 278(37):35451-7. PubMed ID: 12824187 [TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E2 receptor EP1 phosphorylate CREB and mediates MMP2 expression in human cholangiocarcinoma cells. Sun B; Rong R; Jiang H; Zhang H; Wang Y; Bai X; Zhang M; Ma J; Xia S; Shu W; Zhang L; Leng J Mol Cell Biochem; 2013 Jun; 378(1-2):195-203. PubMed ID: 23494562 [TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E2 enhances mitogen-activated protein kinase/Erk pathway in human cholangiocarcinoma cells: involvement of EP1 receptor, calcium and EGF receptors signaling. Zhang L; Jiang L; Sun Q; Peng T; Lou K; Liu N; Leng J Mol Cell Biochem; 2007 Nov; 305(1-2):19-26. PubMed ID: 17551669 [TBL] [Abstract][Full Text] [Related]
6. Antagonism of the prostaglandin E2 EP1 receptor in MDCK cells increases growth through activation of Akt and the epidermal growth factor receptor. Taub M; Parker R; Mathivanan P; Ariff MA; Rudra T Am J Physiol Renal Physiol; 2014 Sep; 307(5):F539-50. PubMed ID: 25007872 [TBL] [Abstract][Full Text] [Related]
7. A novel positive feedback loop between peroxisome proliferator-activated receptor-delta and prostaglandin E2 signaling pathways for human cholangiocarcinoma cell growth. Xu L; Han C; Wu T J Biol Chem; 2006 Nov; 281(45):33982-96. PubMed ID: 16966336 [TBL] [Abstract][Full Text] [Related]
8. Leptin stimulates proliferation and inhibits apoptosis in Barrett's esophageal adenocarcinoma cells by cyclooxygenase-2-dependent, prostaglandin-E2-mediated transactivation of the epidermal growth factor receptor and c-Jun NH2-terminal kinase activation. Ogunwobi O; Mutungi G; Beales IL Endocrinology; 2006 Sep; 147(9):4505-16. PubMed ID: 16740977 [TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenases and prostaglandin E2 receptors in growth plate chondrocytes in vitro and in situ--prostaglandin E2 dependent proliferation of growth plate chondrocytes. Brochhausen C; Neuland P; Kirkpatrick CJ; Nüsing RM; Klaus G Arthritis Res Ther; 2006; 8(3):R78. PubMed ID: 16646980 [TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta (TGF-beta) activates cytosolic phospholipase A2alpha (cPLA2alpha)-mediated prostaglandin E2 (PGE)2/EP1 and peroxisome proliferator-activated receptor-gamma (PPAR-gamma)/Smad signaling pathways in human liver cancer cells. A novel mechanism for subversion of TGF-beta-induced mitoinhibition. Han C; Demetris AJ; Liu Y; Shelhamer JH; Wu T J Biol Chem; 2004 Oct; 279(43):44344-54. PubMed ID: 15294900 [TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E2 promotes human cholangiocarcinoma cell proliferation, migration and invasion through the upregulation of β-catenin expression via EP3-4 receptor. Du M; Shi F; Zhang H; Xia S; Zhang M; Ma J; Bai X; Zhang L; Wang Y; Cheng S; Yang Q; Leng J Oncol Rep; 2015 Aug; 34(2):715-26. PubMed ID: 26058972 [TBL] [Abstract][Full Text] [Related]
12. Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells. Timoshenko AV; Xu G; Chakrabarti S; Lala PK; Chakraborty C Exp Cell Res; 2003 Oct; 289(2):265-74. PubMed ID: 14499627 [TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel mechanism of lymphangiogenesis in lung adenocarcinoma. Su JL; Shih JY; Yen ML; Jeng YM; Chang CC; Hsieh CY; Wei LH; Yang PC; Kuo ML Cancer Res; 2004 Jan; 64(2):554-64. PubMed ID: 14744769 [TBL] [Abstract][Full Text] [Related]
14. The cyclooxygenase-2 inhibitor celecoxib blocks phosphorylation of Akt and induces apoptosis in human cholangiocarcinoma cells. Wu T; Leng J; Han C; Demetris AJ Mol Cancer Ther; 2004 Mar; 3(3):299-307. PubMed ID: 15026550 [TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2-dependent prostaglandin E2 down-regulates intercellular adhesion molecule-1 expression via EP2/EP4 receptors in interleukin-1beta-stimulated human gingival fibroblasts. Noguchi K; Iwasaki K; Shitashige M; Endo H; Kondo H; Ishikawa I J Dent Res; 2000 Dec; 79(12):1955-61. PubMed ID: 11201045 [TBL] [Abstract][Full Text] [Related]
16. Apc deficiency is associated with increased Egfr activity in the intestinal enterocytes and adenomas of C57BL/6J-Min/+ mice. Moran AE; Hunt DH; Javid SH; Redston M; Carothers AM; Bertagnolli MM J Biol Chem; 2004 Oct; 279(41):43261-72. PubMed ID: 15294912 [TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E2 upregulates survivin expression via the EP1 receptor in hepatocellular carcinoma cells. Bai XM; Jiang H; Ding JX; Peng T; Ma J; Wang YH; Zhang L; Zhang H; Leng J Life Sci; 2010 Jan; 86(5-6):214-23. PubMed ID: 20035770 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms involved in PGE2-induced transactivation of the epidermal growth factor receptor in MH1C1 hepatocarcinoma cells. Tveteraas IH; Müller KM; Aasrum M; Ødegård J; Dajani O; Guren T; Sandnes D; Christoffersen T J Exp Clin Cancer Res; 2012 Sep; 31(1):72. PubMed ID: 22967907 [TBL] [Abstract][Full Text] [Related]